TP53 mutations were associated with human BL, its leukemic counterpart L3-type B cell acute lymphoblastic leukemia, B cell chronic lymphocytic leukemia (CLL), and, in particular, its stage of progression known as Richter’s transformation [61]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.